Figure 3.
Figure 3. LDA analysis in VH3-21+ and non-VH3-21 B-CLL. (A) Genes included in the LDA class discriminator. The expression matrix shows the 57 probes that are reliably differentially expressed between the 2 groups, VH3-21+ B-CLL and non-VH3-21 B-CLL. (B) LDA of VH3-21+ and non-VH3-21 B-CLL. Red squares represent VH3-21+ samples; blue squares, non-VH3-21 samples. LDA was applied to the data of the 39 samples by the 57-probe set. Linear discriminants were determined for each sample and plotted. The prediction rate for samples with known class was 100% (P = .01). The median false discovery rate for this predictor was 1.7%.

LDA analysis in VH3-21+ and non-VH3-21 B-CLL. (A) Genes included in the LDA class discriminator. The expression matrix shows the 57 probes that are reliably differentially expressed between the 2 groups, VH3-21+ B-CLL and non-VH3-21 B-CLL. (B) LDA of VH3-21+ and non-VH3-21 B-CLL. Red squares represent VH3-21+ samples; blue squares, non-VH3-21 samples. LDA was applied to the data of the 39 samples by the 57-probe set. Linear discriminants were determined for each sample and plotted. The prediction rate for samples with known class was 100% (P = .01). The median false discovery rate for this predictor was 1.7%.

Close Modal

or Create an Account

Close Modal
Close Modal